Polymeric Nanoparticles for Cancer Photodynamic Therapy

Author(s):  
Claudia Conte ◽  
Sara Maiolino ◽  
Diogo Silva Pellosi ◽  
Agnese Miro ◽  
Francesca Ungaro ◽  
...  
2021 ◽  
Vol 28 ◽  
Author(s):  
Mariana Miretti ◽  
Cesar German Prucca ◽  
Tomas Cristian Tempesti ◽  
Maria Teresa Baumgartner

: Photodynamic therapy has emerged as an effective therapeutic alternative to treat oncological, cardiovascular, dermatological, infectious, and ophthalmic diseases. Photodynamic therapy combines the action of a photosensitizer with light in the presence of oxygen to generate reactive oxygen species capable of reacting with cellular components resulting in injury and, consequently, inducing cellular death. Phthalocyanines are considered good photosensitizers, although most of them are lipophilic, difficulting their administration for clinical use. A strategy to overcome the lack of solubility of phthalocyanines in aqueous media is to incorporate them into different delivery systems. The present review aimed to summarize the current status of the main drug delivery systems used for Zn and Al phthalocyanines and their effect in photodynamic therapy, reported in the last five years. Liposomes, polymeric micelles, polymeric nanoparticles, and gold-nanoparticles constituted some of the most used carriers and were discussed in this review. The latest studies reported strongly suggests that the application of nanotechnologies as delivery systems allow an increase in photodynamic therapy efficacy and reduce side-effects associated with the phthalocyanine administration, which represents a promise for cancer treatments.


2018 ◽  
Vol 551 (1-2) ◽  
pp. 329-338 ◽  
Author(s):  
E. Tugce Sarcan ◽  
Mine Silindir-Gunay ◽  
A. Yekta Ozer

2017 ◽  
Vol 77 ◽  
pp. 935-946 ◽  
Author(s):  
Subramanian Natesan ◽  
Venkateshwaran Krishnaswami ◽  
Chandrasekar Ponnusamy ◽  
Madi Madiyalakan ◽  
Thomas Woo ◽  
...  

2015 ◽  
Vol 14 (7) ◽  
pp. 1329-1336 ◽  
Author(s):  
Moumita Gangopadhyay ◽  
Tanya Singh ◽  
Krishna Kalyani Behara ◽  
S. Karwa ◽  
S. K. Ghosh ◽  
...  

Single-component targeted fluorescent organic polymeric nanoparticles are synthesized from star-shaped 4-arm-PEG containing coumarin for concomitant photodynamic and chemotherapy to efficiently annihilate tumour.


PLoS ONE ◽  
2017 ◽  
Vol 12 (11) ◽  
pp. e0187418 ◽  
Author(s):  
Jeffersson Krishan Trigo Gutierrez ◽  
Gabriela Cristina Zanatta ◽  
Ana Laura Mira Ortega ◽  
Maria Isabella Cuba Balastegui ◽  
Paula Volpato Sanitá ◽  
...  

2020 ◽  
Author(s):  
Johannes Karges ◽  
Jia Li ◽  
Leli Zeng ◽  
Hui Chao ◽  
Gilles Gasser

Photodynamic therapy is a medical technique, which is gaining increasing attention to treat various types of cancer. Among the investigated classes of photosensitizers, the use of Ru(II) polypyridine complexes is gaining momentum. However, the currently investigated compounds generally show poor cancer cell selectivity. As a consequence, high drug doses are needed, which can cause side effects. To overcome this limitation, there is a need for the development of a suitable drug delivery system to increase the amount of PS delivered to the tumor. Herein, we report on the encapsulation of a promising Ru(II) polypyridyl complex into polymeric nanoparticles with terminal biotin groups. Thanks to this design, the particles showed much higher selectivity for cancer cells in comparison to non-cancerous cells in a 2D monolayer and 3D multicellular tumor spheroid model. As a highlight, upon intravenous injection of an identical amount of the Ru(II) polypyridine complex, an improved accumulation inside an adenocarcinomic human alveolar basal epithelial tumor of a mouse by a factor of 8.7 compared to the Ru complex itself was determined. The nanoparticles were found to have a high phototoxic effect upon 1-photon (500 nm) or 2-photon (800 nm) excitation with an eradication of an adenocarcinomic human alveolar basal epithelial tumor inside a mouse. Overall, this work describes, to the best of our knowledge, the first <i>in vivo</i> study demonstrating the cancer cell selectivity of a very promising Ru(II)-based PDT photosensitizer encapsulated into polymeric nanoparticles with terminal biotin groups.


Theranostics ◽  
2018 ◽  
Vol 8 (6) ◽  
pp. 1558-1574 ◽  
Author(s):  
DanRong Hu ◽  
LiJuan Chen ◽  
Ying Qu ◽  
JinRong Peng ◽  
BingYang Chu ◽  
...  

2020 ◽  
Author(s):  
Barbara Silva Figueiredo ◽  
Julyana Noval de Souza Ferreira ◽  
Vannyla Viktória Viana Vasconcelos ◽  
Priscila Ponate de Souza ◽  
Rafaela Vergna De Angeli ◽  
...  

The challenge was always great for lipophilic photosensitizer use in the photodynamic therapy (PDT) for treatment of internal body diseases. Photosensitizer metabolism in liver, incompatibility of the molecules in the gastric acid, aggregation in the bloodstream, opsonization of molecules and phagocyting process hamper the application of the free lipophilic photosensitizer in disease treatment using PDT. This problem has been partially resolved using the drug delivery system to encapsulate the photosensitizer. Many studies have been reported using polymeric nanoparticles to encapsulate the lipophilic photosensitizer showing excellent results for PDT, but few nanoparticulate formulations are available at the pharmacies. The absence of deep knowledge about the influence of synergic effect of parameters used in the nanoparticle preparation on its properties, the photobleaching process of encapsulated photosensitizer and the molecule aggregation into the nanoparticle can decrease the photodynamic efficacy for the lipophilic photosensitizer. Our research group has studied the influence of many parameters on the nanoparticulate properties of several encapsulated phthalocyanines and porphyrin using factorial design, evaluating the free and encapsulated compound aggregation, efficacy to reduce the viability of cancer cells, the photooxidation of the biomolecules and the influence of photobleaching. This work shows the most important results to be consider in the optimization of the polymeric nanoparticle.


2012 ◽  
Vol 19 (6) ◽  
pp. 781-792 ◽  
Author(s):  
R. Chouikrat ◽  
A. Seve ◽  
R. Vanderesse ◽  
H. Benachour ◽  
M. Barberi-Heyob ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document